Strides Pharma Science Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Mar '25
Dec '24
Sep '24
Jun '24
Mar '24
Total Qtr Revenue cr
1,202.37
1,159.28
1,229.52
1,100.22
1,070.49
Other Income Qtr Cr11.985.6228.4112.72-13.55
Operating Revenues Qtr1,190.391,153.671,201.111,087.501,084.04

*All values are in Cr.

Operating Expenses Qtr
972.52
943.36
965.30
870.52
854.30
Operating Profit Qtr
217.87
210.31
235.81
216.98
229.73
EBITDA Qtr Cr
202.43
213.50
260.35
225.96
208.19
Depreciation Qtr
48.86
48.42
50.52
48.59
49.76
Net Profit Qtr
82.19
87.95
93.23
70.20
18.18
Basic EPS Qtr
8.92
9.56
10.14
7.64
1.98
Open Demat Account
+91 -

Open Demat Account
+91 -